ICON plc | Clinical Research Organisation (CRO) for Drug Development

Patient centricity in orphan drug development

Patient involvement in the development of drugs for rare diseases.

COVID-19: Navigating global market access requirements

Recommendations to maxmise HTA success.

Decentralised and hybrid clinical trials

Considerations in planning and executing.

Will US payers give more consideration to PRO data?

ICON surveyed 10 US payers via in-depth phone interviews.

Webinars

Health economic assessments in France (CEESP-HAS)

24 November, 2020. Register now.

Real world data mapping

The landscape of RWD can be difficult to navigate. Learn more in this recent webinar recording.

Using early scientific advice in drug development: Opportunities and challenges webinar

Reducing site burden and increasing trial efficiency

Single platform approach for site training.

On-demand webinar archive

Visit our webinar channel to access our entire library of archived webinars.

Featured Services

COVID-19 clinical operations

Keeping your clinical trial on track in an evolving environment.

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Biosimilars

ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

12 October 2020

Mapping digital health transformation: From digital endpoints to device selection

At ICON, our framework maps the transition from device selection to digital endpoint validation, leading to a better data management and risk mitigation.

08 October 2020

Safety reporting in LATAM is changing, are you ready?

LATAM is evolving to electronic safety reporting and it is essential to be prepared for it.

02 October 2020

Digital health technologies: Implementing innovation in cardiovascular studies during COVID-19

The COVID-19 pandemic has led to the implementation of more efficient trial designs and operational execution, especially with regard to cardiovascular (CV) studies.

29 September 2020

Wearables across phases: How to best incorporate digital endpoints at every stage of clinical research

Once implemented properly, digital endpoints have the potential to enhance any trial, whether observational or interventional, or early or late phase.

22 September 2020

New UKCA (UK Conformity Assessed) marking

As the UK’s transition period to leave the European Union (EU) rapidly comes to an end, the Medicines and Healthcare products Regulatory Agency (MHRA) recently published new guidance on how it will regulate medical devices starting in January 2021.

14 September 2020

Reducing disruptions of cardiovascular trials and ensuring trial integrity during a global pandemic

The COVID-19 pandemic has not only impacted access to healthcare, but also significantly disrupted the conduct of clinical trials investigating therapies intended to treat cardiovascular (CV) diseases.

01 September 2020

Remote management: The new normal in a post-COVID world

As procedures typically carried out on-site continue to be managed remotely, sponsors will need to implement a remote clinical trial management strategy to mitigate further roadblocks that may arise and keep clinical trials moving forward.

20 August 2020

ISO 14155: Increased emphasis on clinical data continues to trend for medical device regulations

Over the past several years, regulations for the medical device industry have continued to evolve placing more emphasis on clinical data and patient safety.

17 August 2020

Best practices for designing digital endpoints for COVID-19 clinical trials amid uncertainty

Utilising data from sensors, wearables and other digital health technologies can provide critical information on COVID- 19 related symptoms and identify digital biomarkers in real- time.

Coronavirus Observatory

Aggregated news, stats and social media on covid-19 clinical trials. Visit Observatory

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

The IVDR journey

Leveraging historical data for use in rare disease trials

Agile Clinical Monitoring

Challenges and opportunities in traumatic brain injury clinical trials

Mitigating the impact of COVID-19 on cardiovascular trials

Patient Centricity